✦ LIBER ✦

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines

✍ Scribed by Nuzhat Husain; E. A. Chiocca; Nikolai Rainov; David N. Louis; Nicholas T. Zervas

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 216 KB
Volume: 95
Category: Article
ISSN: 0001-6322
DOI: 10.1007/s004010050799

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Co-expression of Fas and Fas ligand in h

Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors

✍ B. Frankel; Sharon L. Longo; Timothy C. Ryken 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Expression of Fas and Fas ligand in cuta

Expression of Fas and Fas ligand in cutaneous B-cell lymphomas

✍ Zoi-Toli, Ourania; Meijer, Chris J. L. M.; Oudejans, Joost J.; de Vries, Els; va 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 3 views

Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i

Fas and Fas ligand: expression and solub

Fas and Fas ligand: expression and soluble circulating levels in cutaneous malignant melanoma

✍ P. Redondo; T. Solano; B. VÁzquez; A. Bauza; M. Idoate 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

FAS/FAS ligand expression and induction

FAS/FAS ligand expression and induction of apoptosis in chondrocytes

✍ Sanshiro Hashimoto; Morteza Setareh; Robert L. Ochs; Martin Lotz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 795 KB

Objective. To examine the expression of FasIFas ligand and the role of this ligand/receptor interaction in the regulation of apoptosis in normal human articular chondrocytes and in osteoarthritis (OA) cartilage. Methods. Normal and OA human knee cartilage and cells isolated from these tissues were

Fas and Fas ligand expression in tumor c

Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas

✍ Lucie Peduto Eberl; Louis Guillou; Emilia Saraga; Michael Schröter; Lars E. Fren 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 906 KB

CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apoptosis of activated infiltrating T lymphocytes. Therefore, progressive tumors might express high levels of FasL and develop as immune privileged sites. In this study, we investigated the expression of

Tamoxifen induces apoptosis in Fas+tumor

Tamoxifen induces apoptosis in Fas+tumor cells by upregulating the expression of Fas ligand

✍ Nisha Nagarkatti; Barbara A. Davis 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 371 KB